119 related articles for article (PubMed ID: 9161051)
41. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
[TBL] [Abstract][Full Text] [Related]
42. [HIV integrase inhibitors: a promising development in AIDS research].
Zlotos DP
Pharm Unserer Zeit; 2001; 30(3):186. PubMed ID: 11400663
[No Abstract] [Full Text] [Related]
43. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).
Gleenberg IO; Herschhorn A; Hizi A
J Mol Biol; 2007 Jun; 369(5):1230-43. PubMed ID: 17490682
[TBL] [Abstract][Full Text] [Related]
45. Development of integrase inhibitors of quinolone acid derivatives for treatment of AIDS: an overview.
Luo ZG; Tan JJ; Zeng Y; Wang CX; Hu LM
Mini Rev Med Chem; 2010 Oct; 10(11):1046-57. PubMed ID: 21044030
[TBL] [Abstract][Full Text] [Related]
46. Inhibitors of human immunodeficiency virus integrase.
Pommier Y; Neamati N
Adv Virus Res; 1999; 52():427-58. PubMed ID: 10384246
[TBL] [Abstract][Full Text] [Related]
47. Why have ten or so nontoxic, retrovirus integrase inhibitors not been made available for AIDS treatment? A ten-year experience [correction of experiment] must liberate them.
Mathé G
Biomed Pharmacother; 1999 Dec; 53(10):484-6. PubMed ID: 10665342
[TBL] [Abstract][Full Text] [Related]
48. Anti-HIV-1 integrase potency of methylgallate from Alchornea cordifolia using in vitro and in silico approaches.
Siwe-Noundou X; Musyoka TM; Moses V; Ndinteh DT; Mnkandhla D; Hoppe H; Tastan Bishop Ö; Krause RWM
Sci Rep; 2019 Mar; 9(1):4718. PubMed ID: 30886338
[TBL] [Abstract][Full Text] [Related]
49. HIV-1 integrase multimerization as a therapeutic target.
Feng L; Larue RC; Slaughter A; Kessl JJ; Kvaratskhelia M
Curr Top Microbiol Immunol; 2015; 389():93-119. PubMed ID: 25778682
[TBL] [Abstract][Full Text] [Related]
50. Prediction of the interaction of HIV-1 integrase and its dicaffeoylquinic acid inhibitor through molecular modeling approach.
Hu Z; Chen D; Dong L; Southerland WM
Ethn Dis; 2010; 20(1 Suppl 1):S1-45-9. PubMed ID: 20521384
[TBL] [Abstract][Full Text] [Related]
51. HIV-1 integrase: from biology to chemotherapeutics.
Zeinalipour-Loizidou E; Nicolaou C; Nicolaides A; Kostrikis LG
Curr HIV Res; 2007 Jul; 5(4):365-88. PubMed ID: 17627500
[TBL] [Abstract][Full Text] [Related]
52. HIV-1 integrase binding to its cellular partners: a perspective from computational biology.
Quy VC; Carnevale V; Manganaro L; Lusic M; Rossetti G; Leone V; Fenollar-Ferrer C; Raugei S; Del Sal G; Giacca M; Carloni P
Curr Pharm Des; 2014; 20(21):3412-21. PubMed ID: 24001231
[TBL] [Abstract][Full Text] [Related]
53. Lead screening for HIV-1 integrase (IN) inhibited by traditional Chinese medicine.
Hung TC; Lee WY; Chen KB; Chan YC; Chen CY
Biomed Res Int; 2014; 2014():479367. PubMed ID: 25013783
[TBL] [Abstract][Full Text] [Related]
54. Study on the binding mode of the integrase with DNA via steered molecular dynamics simulation.
Wang CX; Liu M; Li P; Cong XJ; Tan JJ; Chen WZ
Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():4894-7. PubMed ID: 19963867
[TBL] [Abstract][Full Text] [Related]
55. Computational investigation of the anti-HIV activity of Chinese medicinal formula Three-Huang Powder.
Hu JZ; Bai L; Chen DG; Xu QT; Southerland WM
Interdiscip Sci; 2010 Jun; 2(2):151-6. PubMed ID: 20640783
[TBL] [Abstract][Full Text] [Related]
56. Opportunities in drug discovery for treatment of AIDS.
Broom AD
Pharm Res; 1998 Apr; 15(4):515-6. PubMed ID: 9587944
[No Abstract] [Full Text] [Related]
57. Targeting HIV-1 integrase.
Sayasith K; Sauvé G; Yelle J
Expert Opin Ther Targets; 2001 Aug; 5(4):443-464. PubMed ID: 12540259
[TBL] [Abstract][Full Text] [Related]
58. XVI International AIDS Conference.
Das P
Lancet Infect Dis; 2006 Oct; 6(10):624. PubMed ID: 17022139
[No Abstract] [Full Text] [Related]
59. Activity of HIV-1 integrases recovered from subjects with varied rates of disease progression.
Katzman M; Harper AL; Sudol M; Skinner LM; Eyster ME
J Acquir Immune Defic Syndr; 2001 Nov; 28(3):203-10. PubMed ID: 11694825
[TBL] [Abstract][Full Text] [Related]
60. Shooting at a new HIV target.
Palca J
Science; 1990 Jan; 247(4941):410. PubMed ID: 2405485
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
